RNS...contract extension J&J18 Feb 2026 13:48
⬆️ Wee reminder for newbies...
Dr. Marla Dubinsky, CEO and Co-founder of Trellus Health plc said, "The extension of our collaboration with J&J represents further external validation of our platform and the engagement outcomes achieved during the pilot phase. Together with the rollout of TrialSet™ with leading CRO partners, Trellus Health operates across the full programme lifecycle, from clinical trials through commercial deployment, using our proprietary resilience methodology to support engagement and programme success. We are establishing a scalable go-to-market model for pharma, with continued focus on disciplined execution, recurring revenue growth and expansion across immunology and inflammation. We look forward to updating the market on further developments."